XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statement of Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-in Capital
Retained Earnings
Adoption of Accounting Standards Update 2016-13
Retained Earnings
Accumulated other comprehensive loss
Adoption of Accounting Standards Update 2016-13
Total
Beginning Balance (in Shares) at Sep. 30, 2023 9,456            
Beginning Balance at Sep. 30, 2023 $ 94 $ 20,837 $ (15) $ 31,311 $ (6,094) $ (15) $ 46,148
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net Income (Loss)       1,515     1,515
Other comprehensive income (loss)         240   240
Stock-based compensation   705         705
Restricted stock issuance $ 3           3
Restricted stock issuance (in shares) 285            
Issuance of shares under employee stock purchase plan $ 1 83         84
Issuance of shares under employee stock purchase plan (in shares) 13            
Cash dividends paid on common stock       (433)     (433)
Ending Balance (in Shares) at Mar. 31, 2024 9,754            
Ending Balance at Mar. 31, 2024 $ 98 21,625   32,378 (5,854)   48,247
Beginning Balance (in Shares) at Dec. 31, 2023 9,456            
Beginning Balance at Dec. 31, 2023 $ 94 21,133   31,034 (5,787)   46,474
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net Income (Loss)       1,588     1,588
Other comprehensive income (loss)         (67)   (67)
Stock-based compensation   409         409
Restricted stock issuance $ 3           3
Restricted stock issuance (in shares) 285            
Issuance of shares under employee stock purchase plan $ 1 83         84
Issuance of shares under employee stock purchase plan (in shares) 13            
Cash dividends paid on common stock       (244)     (244)
Ending Balance (in Shares) at Mar. 31, 2024 9,754            
Ending Balance at Mar. 31, 2024 $ 98 21,625   32,378 (5,854)   $ 48,247
Beginning Balance (in Shares) at Sep. 30, 2024 9,776           9,776
Beginning Balance at Sep. 30, 2024 $ 98 22,689   29,848 (5,365)   $ 47,270
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net Income (Loss)       364     364
Other comprehensive income (loss)         (258)   (258)
Stock-based compensation   955         955
Restricted stock issuance (in shares) 105            
Issuance of shares under employee stock purchase plan   99         99
Issuance of shares under employee stock purchase plan (in shares) 6            
Purchase of common stock       (384)     (384)
Purchase of common stock (in shares) (24)            
Cash dividends paid on common stock       (593)     $ (593)
Ending Balance (in Shares) at Mar. 31, 2025 9,863           9,863
Ending Balance at Mar. 31, 2025 $ 98 23,743   29,235 (5,623)   $ 47,453
Beginning Balance (in Shares) at Dec. 31, 2024 9,880            
Beginning Balance at Dec. 31, 2024 $ 98 23,196   30,023 (5,861)   47,456
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net Income (Loss)       (108)     (108)
Other comprehensive income (loss)         238   238
Stock-based compensation   448         448
Restricted stock issuance (in shares) 1            
Issuance of shares under employee stock purchase plan   99         99
Issuance of shares under employee stock purchase plan (in shares) 6            
Purchase of common stock       (384)     (384)
Purchase of common stock (in shares) (24)            
Cash dividends paid on common stock       (296)     $ (296)
Ending Balance (in Shares) at Mar. 31, 2025 9,863           9,863
Ending Balance at Mar. 31, 2025 $ 98 $ 23,743   $ 29,235 $ (5,623)   $ 47,453